Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis

Clinical Endocrinology

Volumn 47, Issue 2, 1997, Pages 215-221

  Nagasaka, Shoichiro ^a   Sugimoto, Hideharu ^a   Nakamura, Tomoatsu ^a   Kusaka, Ikuyo ^a   Fujisawa, Genro ^a   Sakuma, Nobuko ^a   Tsuboi, Yasushi ^a   Fukuda, Shuichi ^a   Honda, Kazufumi ^a   Okada, Koji ^a   Ishikawa, San E ^a   Saito, Toshikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTITHYROID AGENT; COLLAGEN TYPE 1; THYROID HORMONE;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE REMODELING; CLINICAL ARTICLE; FEMALE; GRAVES DISEASE; HUMAN; MALE; METACARPAL BONE; OSSIFICATION; PRIORITY JOURNAL; RADIOGRAPHY; THYROID HORMONE BLOOD LEVEL; THYROTOXICOSIS; TRABECULAR BONE;

EID: 8544225770     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2401045.x     Document Type: Article

References (32)

1. Allain, T.J., Chambers, T.J., Flanagan, A.M. & McGregor, A.M. (1992) Triiodothyronine stimulates rat osteoclastic bone resorption by an indirect effect. Journal of Endocrinology, 133, 327-331.
2. Britto, J.M., Fenton, A.J., Holloway, W.R. & Nicholson, G.C. (1994) Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology, 134, 169-176.
3. Delmas, P.D., Gineyts, E., Bertholin, A., Garnero, P. & Marchand, F. (1993) Immunoassay of pyridinoline excretion in normal adults and in Paget's disease. Journal of Bone and Mineral Research, 8, 645-650.
4. Diamond, T., Vine, J., Smart, R. & Butler, P. (1994) Thyrotoxic bone disease in women: a potentially reversible disorder. Annals of Internal Medicine, 120, 8-11.
5. Eriksen, E.F., Mosekilde, L. & Melsen, F. (1985) Trabecular bone remodeling and bone balance in hyperthyroidism. Bone, 6, 421-428.
6. Földes, J., Tarján, G., Szathmari, M., Varga, F., Krasznai, I. & Horvath, Cs. (1993) Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clinical Endocrinology, 38, 521-527.
7. Garnero, P., Vassy, V., Bertholin, A., Riou, J.P. & Delmas, P.D. (1994) Markers of bone turnover in hyperthyroidism and the effects of treatment. Journal of Clinical Endocrinology and Metabolism, 78, 955-959.
8. Garrel, D.R., Delmas, P.D., Malaval, L. & Tourniaire, J. (1986) Serum bone Gla protein: a marker of bone turnover in hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 62, 1052-1055.
9. Harvey, R.D., McHardy, K.C., Reid, I.W., Paterson, F., Bewsher, P.D., Duncan, A. & Robins, S.P. (1991) Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. Journal of Clinical Endocrinology and Metabolism, 72, 1189-1194.
10. Kawaguchi, H., Matsumoto, T., Kurokawa, T., Orimo, H., Mizunashi, K., Takuwa, Y., Niimi, H., Shiraki, M., Ohara, T., Shishiba, Y., Tsuchiya, Y., Takahashi, H., Takatsuki, K., Seino, Y., Morii, H., Fujita, T., Okamoto, S. & Ogata, E. (1990) Serum levels of BGP determination by two-site immunoradiometric assay (IRMA) using monoclonal antibodies. Clinical Endocrinology (Tokyo), 38, 1291-1296.
11. Krølner, B., Jørgensen, J.V. & Nielsen, S.P. (1983) Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clinical Endocrinology, 18, 439-446.
12. Lee, M.S., Kim, S.Y., Lee, M.C., Cho, B.Y., Lee, H.K., Koh, C-S & Min, H.K. (1990) Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 70, 766-770.
13. Lukert, B.P., Higgins, J.C. & Stoskopf, M.M. (1986) Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. Journal of Clinical Endocrinology and Metabolism, 62, 1056-1058.
14. MacLeod, J.M., McHardy, K.C., Harvey, R.D., Duncan, A., Reid, I.W., Bewsher, P.D. & Robins, S.P. (1993) The early effects of radioiodine therapy for hyperthyroidism on biochemical indices of bone turnover. Clinical Endocrinology, 38, 49-53.
15. Meema, H.E. & Schatz, D.L. (1970) Simple radiologic demonstration of cortical bone loss in thyrotoxicosis. Radiology, 97, 9-15.
16. Meema, H.E. & Meema, S. (1987) Postmenopausal osteoporosis: simple screening method for diagnosis before structural failure. Radiology, 164, 405-410.
17. Melkko, J., Niemi, S., Risteli, L. & Risteli, J. (1990) Radioimmunoassay of the carboxyterminal propeptide of human type 1 procollagen. Clinical Chemistry 36, 1328-1332.
18. Meunier, P.J., S-Bianchi, G.G., Edouard, C.M., Eng, B.S., Bernard, J.C., Courpron, P. & Vignon, G.E. (1972) Bony manifestations of thyrotoxicosis. Orthopedic Clinics of North America, 3, 745-774.
19. Mosekilde, L. & Melsen, F. (1978) Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism II: bone histomorphometry. Acta Endocrinologica (Copenh), 87, 751-758.
20. Mosekilde, L., Melsen, F., Bagger, J.P., Myhre-Jensen, O. & Sørensen, N.S. (1977) Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinologica (Copenh), 85, 515-525.
21. Mosekilde, L., Christensen, M.S., Melsen, F. & Sørensen, N.S. (1978) Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism I: chemical quantities in serum and urine. Acta Endocrinologica (Copenh), 87, 743-750.
22. Mudde, A.H., Reijnders, F.J.L. & Kruseman, A.C.N. (1992) Peripheral bone density in women with untreated multinodular giotre. Clinical Endocrinology, 37, 35-39.
23. Mudde, A.H., Houben, A.J.H.M. & Kruseman, A.C.N. (1994) Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clinical Endocrinology, 41, 421-424.
24. Risteli, J., Elomaa, I., Niemi, S., Novamo, A. & Risteli, L. (1993) Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clinical Chemistry, 39, 635-640.
25. Rizzoli, R., Poser, J. & Burgi, U. (1986) Nuclear thyroid hormone receptors in cultured bone cells. Metabolism, 35, 71-74.
26. Rosen, C.J. & Adler, R.A. (1992) Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. Journal of Clinical Endocrinology and Metabolism, 75, 1531-1534.
27. Rosen, H.N., Moses, A.C., Gundberg, C., Kung, V.T., Seyedin, S.M., Chen, T., Holick, M. & Greenspan, S.L. (1993) Therapy with parental pamidronate prevents thyroid hormone-induced bone turnover in humans. Journal of Clinical Endocrinology and Metabolism, 77, 664-669.
28. Sato, K., Han, D.C., Fujii, Y., Tsushima, T. & Shizume, K. (1987) Thyroid hormone stimulates alkaline phosphatase activity in cultured rat osteoblastic cells (ROS 17/2.8) through 3,5,3′-triiodo-L-thyronine nuclear receptors. Endocrinology, 120, 1873-1881.
29. Seeman, E., Hopper, J.L., Bach, L.A., Cooper, M.E., Parkinson, E., McKay, J. & Jerums, G. (1989) Reduced bone mass in daughters of women with osteoporosis. New England Journal of Medicine, 320, 554-558.
30. Toh, S.H., Claunch, B.C. & Brown, P.M. (1985) Effect of hyperthyroidism and its treatment on bone mineral content. Archives of Internal Medicine, 145, 883-886.
31. Wakasugi, M., Wakao, R., Tawata, M., Gan, N., Koizumi, K. & Onaya, T. (1993) Bone mineral density in patients with hyperthyroidism measured by dual energy x-ray absorptiometry. Clinical Endocrinology, 38, 283-286.
32. Wilson, J.S. & Genant, H.K. (1979) In vivo assessment of bone metabolism using the cortical striation index. Investigative Radiology, 14, 131-136.